Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects

Journal of Thoracic and Cardiovascular Surgery

Volumn 146, Issue 6, 2013, Pages 1501-1508

  Kurobe, Hirotsugu ^a,c   Matsuoka, Yuki ^a   Hirata, Yoichiro ^a,b   Sugasawa, Noriko ^a   Maxfield, Mark W ^c   Sata, Masataka ^b   Kitagawa, Tetsuya ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPIONITRILE; ANGIOTENSIN II; AZELNIDIPINE; GELATINASE A; GELATINASE B; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; AORTA ANEURYSM; AORTA WALL; ARTICLE; CARDIOVASCULAR MORTALITY; DISEASE COURSE; HEART PROTECTION; INCIDENCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

Β-AMINOPROPIONITRILE; 16; 26.1; 29; AA; AORTIC ANEURYSM; BAPN; ELASTICA VAN GIESON; EVG; H&E; HEMATOXYLIN AND EOSIN; MATRIX METALLOPROTEINASE; MMP; REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION; RT-PCR; TNF-Α; TUMOR NECROSIS FACTOR-ALPHA;

AMINOPROPIONITRILE; ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA, ABDOMINAL; AORTA, THORACIC; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; AZETIDINECARBOXYLIC ACID; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; SIRTUIN 1; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888050809     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.02.073     Document Type: Article

References (37)

1. R. Sakata, Y. Fujii, and H. Kuwano Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery Gen Thorac Cardiovasc Surg 58 2010 356 383
2. R.E. Lewiss, D.J. Egan, and A. Shreves Vascular abdominal emergencies Emerg Med Clin North Am 29 2011 253 272 viii
3. A.N. Assar, and C.K. Zarins Ruptured abdominal aortic aneurysm: a surgical emergency with many clinical presentations Postgrad Med J 85 2009 268 273
4. M. Prinssen, E.L. Verhoeven, J. Buth, P.W. Cuypers, M.R. van Sambeek, and R. Balm Dutch Randomized Endovascular Aneurysm Management (DREAM)Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms N Engl J Med 351 2004 1607 1618
5. J.L. De Bruin, A.F. Baas, J. Buth, M. Prinssen, E.L. Verhoeven, and P.W. Cuypers Long-term outcome of open or endovascular repair of abdominal aortic aneurysm N Engl J Med 362 2010 1881 1889
6. A.C. Braverman Medical management of thoracic aortic aneurysm disease J Thorac Cardiovasc Surg 145 2013 S2 S6
7. E.M. Isselbacher Thoracic and abdominal aortic aneurysms Circulation 111 2005 816 828
8. S.M. Krishna, A.E. Dear, P.E. Norman, and J. Golledge Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm Atherosclerosis 212 2010 16 29
9. P.C. Tang, M.A. Coady, C. Lovoulos, A. Dardik, M. Aslan, and J.A. Elefteriades Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms Circulation 112 2005 1098 1105
10. M. Sawabe Vascular aging: from molecular mechanism to clinical significance Geriatr Gerontol Int 10 Suppl 1 2010 S213 S220
11. A. Lopez-Candales, D.R. Holmes, S. Liao, M.J. Scott, S.A. Wickline, and R.W. Thompson Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms Am J Pathol 150 1997 993 1007
12. T.J. Schlatmann, and A.E. Becker Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm Am J Cardiol 39 1977 13 20
13. I. Sibon, P. Sommer, J.M. Lamaziere, and J. Bonnet Lysyl oxidase deficiency: a new cause of human arterial dissection Heart 91 2005 e33
14. J. Behmoaras, S. Slove, S. Seve, R. Vranckx, P. Sommer, and M.P. Jacob Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta Rejuvenation Res 11 2008 883 889
15. H. Yanagisawa, and E.C. Davis Unraveling the mechanism of elastic fiber assembly: the roles of short fibulins Int J Biochem Cell Biol 42 2010 1084 1093
16. Y. Kanematsu, M. Kanematsu, C. Kurihara, T.L. Tsou, Y. Nuki, and E.I. Liang Pharmacologically induced thoracic and abdominal aortic aneurysms in mice Hypertension 55 2010 1267 1274
17. H.M. McCallum Experimental lathyrism in mice J Pathol Bacteriol 89 1965 625 636
18. H.M. McCallum Experimental lathyrism in tissue culture J Pathol Bacteriol 89 1965 637 644
19. T. Matsui, S. Yamagishi, K. Nakamura, and H. Inoue Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression in endothelial cells J Int Med Res 34 2006 671 675
20. Y. Naito, M. Shimozawa, H. Manabe, N. Nakabe, K. Katada, and S. Kokura Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species Eur J Pharmacol 546 2006 11 18
21. K. Nakano, K. Egashira, K. Ohtani, Z. Gang, E. Iwata, and M. Miyagawa Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice Atherosclerosis 196 2008 172 179
22. K. Shinomiya, K. Mizushige, M. Fukunaga, H. Masugata, K. Ohmori, and M. Kohno Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells J Int Med Res 32 2004 170 175
23. D. Weiss, J.J. Kools, and W.R. Taylor Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice Circulation 103 2001 448 454
24. N. Gletsu, T.N. Doan, J. Cole, R.L. Sutliff, and K.E. Bernstein Angiotensin II-induced hypertension in mice caused an increase in insulin secretion Vascul Pharmacol 42 2005 83 92
25. T. Jinno, M. Iwai, Z. Li, J.M. Li, H.W. Liu, and T.X. Cui Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan Hypertension 43 2004 263 269
26. L. Guarente Franklin H. Epstein Lecture: Sirtuins, aging, and medicine N Engl J Med 364 2011 2235 2244
27. C.G. Collins, and A.L. Leahy Screening of abdominal aortic aneurysms Surgeon 4 2006 83 85
28. J.L. Cronenwett Screening for abdominal aortic aneurysms Ann Intern Med 143 2005 309 author reply 309-10
29. N. Sakalihasan, R. Limet, and O.D. Defawe Abdominal aortic aneurysm Lancet 365 2005 1577 1589
30. N.L. Weintraub Understanding abdominal aortic aneurysm N Engl J Med 361 2009 1114 1116
31. K. Ley, Y.I. Miller, and C.C. Hedrick Monocyte and macrophage dynamics during atherogenesis Arterioscler Thromb Vasc Biol 31 2011 1506 1516
32. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nature Immunol 12 2011 204 212
33. Y. Nuki, M.M. Matsumoto, E. Tsang, W.L. Young, N. van Rooijen, and C. Kurihara Roles of macrophages in flow-induced outward vascular remodeling J Cereb Blood Flow Metab 29 2009 495 503
34. R. Ota, C. Kurihara, T.L. Tsou, W.L. Young, Y. Yeghiazarians, and M. Chang Roles of matrix metalloproteinases in flow-induced outward vascular remodeling J Cereb Blood Flow Metab 29 2009 1547 1558
35. A.J. Donato, K.A. Magerko, B.R. Lawson, J.R. Durrant, L.A. Lesniewski, and D.R. Seals SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans J Physiol 589 Pt 18 2011 4545 4554
36. A. Takemura, K. Iijima, H. Ota, B.K. Son, Y. Ito, and S. Ogawa Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells Arterioscler Thromb Vasc Biol 31 2011 2054 2062
37. T.T. Schug, Q. Xu, H. Gao, A. Peres-da-Silva, D.W. Draper, and M.B. Fessler Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress Mol Cell Biol 30 2010 4712 4721